S100A9 and colorectal carcinoma: Over the past few decades, increasing experimental evidence has demonstrated that either S100A9 or MDSCs contribute to tumor development (5, 16), suggesting that the detection of S100A9 and/or MDSCs in peripheral blood may be a diagnostic and progression prediction marker for CRC.